14-day Premium Trial Subscription Sign Up For FreeGet Free

Stock Market Week 20 - The Game Is On! Click to watch.

$3.08 (0.65%)

Volume: 108.04k

Closed: May 16, 2022

Hollow Logo Score: -4.806

aTyr Pharma Stock Forecast

BUY SELL NASDAQ:LIFE
$3.08 (0.65%)

Volume: 108.04k

Closed: May 16, 2022

Score Hollow Logo -4.806

aTyr Pharma Stock Forecast NASDAQ:LIFE

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-05-10 549.35% RBC Capital $22.00 $20.00 Maintains Outperform
2021-11-11 257.14% HC Wainwright & Co. $18.00 $11.00 Maintains Buy
2021-10-12 614.29% RBC Capital $22.00 Initiates Coverage On Outperform
2021-09-21 516.88% Piper Sandler $19.00 Initiates Coverage On Overweight
2021-09-14 581.82% Roth Capital $20.00 $21.00 Maintains Buy
2021-09-14 549.35% Oppenheimer $14.00 $20.00 Maintains Outperform
2021-09-13 484.42% HC Wainwright & Co. $13.00 $18.00 Maintains Buy
2021-05-18 387.01% JonesTrading $15.00 Initiates Coverage On Buy
2021-03-24 354.55% Oppenheimer $12.00 $14.00 Maintains Outperform
2021-03-16 549.35% Roth Capital $15.00 $20.00 Maintains Buy
2020-08-17 322.08% HC Wainwright & Co. $13.00 Upgrades Neutral Buy
2020-03-27 - HC Wainwright & Co. - Downgrades Buy Neutral
2020-03-02 159.74% Oppenheimer $8.00 Initiates Coverage On Outperform
2019-11-05 159.74% HC Wainwright & Co. $8.00 Initiates Coverage On Buy

LIFE Stock Trend

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.97 is broken, it will firstly indicate a stronger fall rate.

Given the current short-term trend, the stock is expected to fall -24.94% during the next 3 months and, with a 90% probability hold a price between $2.23 and $3.73 at the end of this 3-month period.

Data

Date Bottom Mid Top
2022-05-18 $2.94 $3.94 $4.94
2022-05-19 $2.91 $3.91 $4.91
2022-05-20 $2.88 $3.88 $4.88
2022-05-23 $2.86 $3.85 $4.85
2022-05-24 $2.83 $3.83 $4.83
2022-05-25 $2.80 $3.80 $4.80
2022-05-26 $2.77 $3.77 $4.77
2022-05-27 $2.75 $3.74 $4.74
2022-05-31 $2.72 $3.72 $4.72
2022-06-01 $2.69 $3.69 $4.69
2022-06-02 $2.66 $3.66 $4.66
2022-06-03 $2.64 $3.63 $4.63
2022-06-06 $2.61 $3.61 $4.61
2022-06-07 $2.58 $3.58 $4.58
2022-06-08 $2.55 $3.55 $4.55
2022-06-09 $2.53 $3.52 $4.52
2022-06-10 $2.50 $3.50 $4.50
2022-06-13 $2.47 $3.47 $4.47
2022-06-14 $2.44 $3.44 $4.44
2022-06-15 $2.42 $3.41 $4.41
2022-06-16 $2.39 $3.39 $4.39
2022-06-17 $2.36 $3.36 $4.36
2022-06-21 $2.33 $3.33 $4.33
2022-06-22 $2.31 $3.30 $4.30
2022-06-23 $2.28 $3.28 $4.28
2022-06-24 $2.25 $3.25 $4.25
2022-06-27 $2.22 $3.22 $4.22
2022-06-28 $2.20 $3.19 $4.19
2022-06-29 $2.17 $3.17 $4.17
2022-06-30 $2.14 $3.14 $4.14

About aTyr Pharma

aTyr Pharma aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and clinical development of Physiocrine-based therapeutics for patients suffering from severe and rare diseases. The company develops Resolaris, which is in Phase Ib/II clinical trials for treating adult patients with facioscapulohumeral muscular dystrophy (FSHD), a rare genetic myopathy with an immune component; patients with early onset FSHD; and adult patients with limb-gir... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 108 000+ Happy Subscribers

Don't miss out on the runners!

Sign for StockInvest.us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT